WHO guideline on mass drug administration of azithromycin to children under five years of age to promote child survival
The purpose of the guideline was to provide an evidence-informed recommendation on whether mass drug administration of azithromycin, as a public health intervention for the reduction of under-five mortality, should (a) be rolled out universally in low- and middle-income countries, (b) be applied onl...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Geneva
World Health Organization
[2020], 2020
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The purpose of the guideline was to provide an evidence-informed recommendation on whether mass drug administration of azithromycin, as a public health intervention for the reduction of under-five mortality, should (a) be rolled out universally in low- and middle-income countries, (b) be applied only in some situational contexts in low-and middle-income countries or (c) not be used at all |
|---|---|
| Physical Description: | 1 PDF file (xii, 38 pages) illustrations |
| ISBN: | 9789240009585 9789240009592 |